Disc Medicine Future Growth
Future criteria checks 0/6
Disc Medicine's earnings are forecast to decline at 9.8% per annum while its annual revenue is expected to grow at 78.7% per year. EPS is expected to decline by 5% per annum. Return on equity is forecast to be -32.9% in 3 years.
Key information
-9.8%
Earnings growth rate
-5.0%
EPS growth rate
| Biotechs earnings growth | 24.4% |
| Revenue growth rate | 78.7% |
| Future return on equity | -32.9% |
| Analyst coverage | Good |
| Last updated | 25 Jun 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3 | -180 | -137 | -115 | 5 |
| 12/31/2025 | N/A | -144 | -110 | -112 | 6 |
| 12/31/2024 | N/A | -119 | -112 | -144 | 7 |
| 3/31/2024 | N/A | -81 | -72 | -72 | N/A |
| 12/31/2023 | N/A | -76 | -74 | -73 | N/A |
| 9/30/2023 | N/A | -64 | -65 | -65 | N/A |
| 6/30/2023 | N/A | -66 | -68 | -68 | N/A |
| 3/31/2023 | N/A | -60 | -64 | -64 | N/A |
| 12/31/2022 | N/A | -47 | -42 | -42 | N/A |
| 9/30/2022 | N/A | -44 | -39 | -39 | N/A |
| 6/30/2022 | N/A | -37 | -35 | -34 | N/A |
| 3/31/2022 | N/A | -37 | -33 | -33 | N/A |
| 12/31/2021 | N/A | -36 | -28 | -28 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IRON is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IRON is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IRON is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IRON is forecast to have no revenue next year.
High Growth Revenue: IRON is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IRON is forecast to be unprofitable in 3 years.